WO2013109213A3 - Pharmaceutical formulations comprising tiotropium - Google Patents

Pharmaceutical formulations comprising tiotropium Download PDF

Info

Publication number
WO2013109213A3
WO2013109213A3 PCT/TR2013/000025 TR2013000025W WO2013109213A3 WO 2013109213 A3 WO2013109213 A3 WO 2013109213A3 TR 2013000025 W TR2013000025 W TR 2013000025W WO 2013109213 A3 WO2013109213 A3 WO 2013109213A3
Authority
WO
WIPO (PCT)
Prior art keywords
tiotropium
pharmaceutical formulations
order
dry powder
relates
Prior art date
Application number
PCT/TR2013/000025
Other languages
French (fr)
Other versions
WO2013109213A2 (en
Inventor
Mahmut Bilgic
Original Assignee
Mahmut Bilgic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mahmut Bilgic filed Critical Mahmut Bilgic
Publication of WO2013109213A2 publication Critical patent/WO2013109213A2/en
Publication of WO2013109213A3 publication Critical patent/WO2013109213A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention relates to pharmaceutical formulations in dry powder comprising tiotropium in order to be used in respiratory tract diseases.
PCT/TR2013/000025 2012-01-16 2013-01-16 Pharmaceutical formulations comprising tiotropium WO2013109213A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201200492 2012-01-16
TR2012/00492 2012-01-16

Publications (2)

Publication Number Publication Date
WO2013109213A2 WO2013109213A2 (en) 2013-07-25
WO2013109213A3 true WO2013109213A3 (en) 2013-09-06

Family

ID=48237229

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/TR2013/000025 WO2013109213A2 (en) 2012-01-16 2013-01-16 Pharmaceutical formulations comprising tiotropium
PCT/TR2013/000028 WO2013109216A2 (en) 2012-01-16 2013-01-16 Preparation of dry powder formulations comprising tiotropium

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/TR2013/000028 WO2013109216A2 (en) 2012-01-16 2013-01-16 Preparation of dry powder formulations comprising tiotropium

Country Status (2)

Country Link
EP (1) EP2804591A2 (en)
WO (2) WO2013109213A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136919A1 (en) * 2002-11-28 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
EP2172190A1 (en) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
WO2011093819A2 (en) * 2010-01-28 2011-08-04 Mahmut Bilgic New combination comprising tiotropium
WO2011093820A2 (en) * 2010-01-28 2011-08-04 Mahmut Bilgic A pharmaceutical combination comprising tiotropium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (en) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
WO2011152804A2 (en) * 2010-06-03 2011-12-08 Mahmut Bilgic Process for dry powder formulations

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136919A1 (en) * 2002-11-28 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
EP2172190A1 (en) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
WO2011093819A2 (en) * 2010-01-28 2011-08-04 Mahmut Bilgic New combination comprising tiotropium
WO2011093820A2 (en) * 2010-01-28 2011-08-04 Mahmut Bilgic A pharmaceutical combination comprising tiotropium

Also Published As

Publication number Publication date
WO2013109213A2 (en) 2013-07-25
EP2804591A2 (en) 2014-11-26
WO2013109216A2 (en) 2013-07-25
WO2013109216A3 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
HK1255336A1 (en) Pharmaceutical formulations and processes of preparation thereof
ZA201703992B (en) Inhalable pharmaceutical compositions
HK1205690A1 (en) Pharmaceutical composition and administration thereof
HK1204989A1 (en) Inhalable dry powders
IL222268A (en) Substituted pyrrolo-pyridines, pharmaceutical compositions comprising them, combined compositions comprising them and their use in the manufacture of medicaments
HK1208801A1 (en) Orally administered medical composition
IL235020A0 (en) N-phenyl benzenesulfonamide derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
EP2906202A4 (en) Oral drug delivery formulations
IL237839A0 (en) Hydropyrrolopyrrole derivatives, their preparation and pharmaceutical compositions containing them
HK1203812A1 (en) Novel pharmaceutical formulations
IL235414A (en) Pyrrolotriazinone derivatives, their preparation and pharmaceutical compositions containing them
IL236057B (en) 1,2,4-triazine-6-carboxamide derivatives and pharmaceutical compositions comprising them
HK1215388A1 (en) Inhalable pharmaceutical compositions and the inhaler devices containing them
HK1211021A1 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions 2--6--9--9h-
IL233825A (en) 1h-indazole-3-carboxamide compounds, compositions comprising them and uses thereof in the preparation of medicaments
EP3020417A4 (en) Pharmaceutical composition for respiratory administration
HK1215167A1 (en) Inhalable pharmaceutical compositions and the inhaler devices containing them
HK1204289A1 (en) Topical ophthalmological pharmaceutical composition containing cediranib
EP2933290A4 (en) Composition for forming complex, complex formed therefrom, and composition for oral administration including said complex
EP2866792A4 (en) Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture
EP2868319A4 (en) Aripiprazole oral pharmaceutical preparation
IL238826A (en) Imidazol-piperidinyl derivatives, their preparation and pharmaceutical compositions containing them
EP2926811A4 (en) Artemether-containing pharmaceutical composition, preparation, and use thereof
WO2013109213A3 (en) Pharmaceutical formulations comprising tiotropium
HK1209339A1 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13720137

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13720137

Country of ref document: EP

Kind code of ref document: A2